Cancer epigenetics comes of age

Nature Genetics

Volumn 21, Issue 2, 1999, Pages 163-167

  Jones, Peter A ^a   Laird, Peter W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DNA METHYLATION; GENE INACTIVATION; GENE SILENCING; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASMS;

EID: 0032960181     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5947     Document Type: Review

References (74)

1. Yang, A.S., Jones, P.A. & Shibata, A. The mutational burden of 5-methylcytosine. in Epigenetic Mechanisms of Gene Regulation (eds Riggs, A.D., Martienssen, R.A., and Russo, V.E.A.) 77-94 (Cold Spring Harbor Laboratory Press, Cold Spring Harbour, 1996).
2. Razin, A. & Cedar, H. DNA methylation and gene expression. Microbiol. Rev. 55, 451-458 (1991).
3. Yeivin, A. & Razin, A. Gene methylation patterns and expression, in DNA Methylation: Molecular Biology and Biological Significance (eds Jost, J.P. & Saluz, H.P.) 523-568 (Birkhauser Verlag, Basel, 1993).
4. Kass, S.U., Pruss, D. & Wolffe, A.P. How does DNA methylation repress transcription? Trends Genet. 13, 444-449 (1997).
5. Jones, P.A. The methylation paradox. Trends Genet. (in press).
6. Razin, A. & Riggs, A.D. DNA methylation and gene function. Science 210, 604-610 (1980).
7. Stoger, R. et al. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73, 61-71 (1993).
8. Larsen, F., Solheim, J. & Prydz, H. A methylated CpG island 3′ in the apolipoprotein-E gene does not repress its transcription. Hum. Mol. Genet. 2, 775-780 (1993).
9. Barry, C., Faugeron, G. & Rossignol, J.-L. Methylation induced premeiotically in Ascobolus: coextension with DNA repeat lengths and effect on transcript elongation. Proc. Natl Acad. Sci. USA 90, 4557-4561 (1993).
10. Rountree, M.R. & Selker, E.U. DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa. Genes Dev. 11, 2383-2395 (1997).
11. Clark, S.J., Harrison, J. & Molloy, P.L. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195, 67-71 (1997).
12. Prendergast, G.C. & Ziff, E.B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251, 186-189 (1991).
13. Zhang, X.Y., Ehrlich, K.C., Wang, R.Y. & Ehrlich, M. Effect of site-specific DNA methytation and mutagenesis on recognition by methylated DNA-binding protein from human placenta. Nucleic Acids Res. 14, 8387-8397 (1986).
14. Asiedu, C.K., Scotto, L., Assoian, R.K. & Ehrlich, M. Binding of AP-1/CREB proteins and of MDBP to contiguous sites downstream of the human TGF-β 1 gene. Biochim. Biophys. Acta 1219, 55-63 (1994).
15. Bestor, T.H. Gene silencing. Methylation meets acetylation. Nature 393, 311-312 (1998).
16. Nan, X., Campoy, F.J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481 (1997).
17. Nan, X. et al. Transcriptional repression by the methyl CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
18. Jones, P.L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187-191 (1998).
19. Bird, A.P. CpG-rich islands and the function of DNA methylation. Nature 321, 209-213 (1986)
20. Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261-282 (1987).
21. Larsen, F., Gundersen, G., Lopez, R. & Prydz, H. CpG islands as gene markers in the human genome. Genomics 13, 1095-1107 (1992).
22. Wutz, A. et al. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389, 745-749 (1997).
23. Singer-Sam, J. & Riggs, A.D. X chromosome inactivation and DNA methylation, in DNA Methylation: Molecular Biology and Biological Significance (eds Jost, J.P. & Saluz, H.P.) 358-384 (Birkhauser Verlag, Basel, 1993).
24. Issa, J.P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536-540 (1994).
25. Issa, J.P., Vertino, P.M., Boehm, C.D., Newsham, I.F. & Baylin, S.B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl Acad. Sci. USA 93, 11757-11762 (1996).
26. Jones, P.A. et al. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl Acad. Sci. USA 87, 6117-6121 (1990).
27. Antequera, F., Boyes, J. & Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62, 503-514 (1990).
28. Feinberg, A.P., Gehrke, C.W., Kuo, K.C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159-1161 (1988).
29. Jones, P.A. DNA methylation errors and cancer. Cancer Res. 56, 2463-2467 (1996).
30. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. & Issa, J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196 (1998).
31. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
32. Gonzalez-Zuleta, M. et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531-4535 (1995)
33. Gonzalgo, M.L. et al. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 58, 1245-1252 (1998).
34. Ohtani-Fujita, N. et al. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet. Cytogenet. 98, 43-49 (1997).
35. Prowse, A.H. et al. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am. J. Hum. Genet. 60, 765-771 (1997).
36. Herman, J.G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 95, 6870-6875 (1998).
37. Lock, L.F., Takagi, N. & Martin, G.R. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell 48, 39-46 (1987).
38. Grant, M., Zuccotti, M. & Monk, M. Methylation of CpG sites of two X-linked genes coincides with X-inactivation in the female mouse embryo but not in the germ line. Nature Genet. 2, 161-166 (1992).
39. Singer-Sam, J. et al. Use of a Hpall-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol. Cell. Biol. 10, 4987-4989 (1990).
40. Norris, D.P., Brockdorff, N. & Rastan, S. Methytation status of CpG-rich islands on active and inactive mouse X chromosomes. Mamm. Genome. 1, 78-83 (1991).
41. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
42. Laird, P.W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197-205 (1995).
43. Moulton, T. et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet. 7, 440-447 (1994).
44. Steenman, M.J. et al. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet. 7, 433-439 (1994).
45. Ohtani-Fujita, N. et al. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8, 1063-1067 (1993).
46. Veigl, M.L. et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA 95, 8698-8702 (1998).
47. Cunningham, J.M. et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455-3460 (1998).
48. Lengauer, C., Kinzler, K.W. & Vogelstein, B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl Acad. Sci. USA 94, 2545-2550 (1997).
49. Ahuja, N. et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57, 3370-3374 (1997).
50. Hussain, S.P. & Harris, C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58, 4023-4037 (1998).
51. Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440 (1994).
52. Hatada, I., Sugama, T. & Mukai, T. A new imprinted gene cloned by a methylation-sensitive genome scanning method. Nucleic Acids Res. 21, 5577-5582 (1993).
53. Ushijima, T. et al. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc. Natl Acad. Sci. USA 94, 2284-2289 (1997).
54. Gonzalgo, M.L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594-599 (1997).
55. Huang, T.H. et al. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030-1034 (1997).
56. Toyota, M. et al. Identification of novel aberrantly methylated CpG islands in colorectal carcinoma. Proc. Am. Assoc. Cancer Res. 39, 95 (1998).
57. Frommer, M. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).
58. Rein, T., DePamphilis, M.L. & Zorbas, H. Identifying 5-methylcytosine and related modifications in DNA genomes. Nucleic Acids Res. 26, 2255-2264 (1998).
59. Gonzalgo, M.L. et al. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res. 57, 5336-5347 (1997).
60. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821-9826 (1996).
61. Gonzalgo, M.L. & Jones, P.A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 25, 2529-2531 (1997).
62. Xiong, Z. & Laird, P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25, 2532-2534 (1997).
63. Bender, C.M., Pao, M.M. & Jones, P.A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 58, 95-101 (1998).
64. Lübbert, M. et al. Cytogenic response to low-dose 5-aza-2′-deoxycytidine (DAC) in poor risk myelodysplastic syndromes (MDS) - phase II study results. Blood 90 (suppl. 1), 582a (1997).
65. Silverman, L.R. et al. A randomized controlled trial of subcutaneous azacytidine (aza C) in patients with the myelodysplastic syndrome (MDS): a study of the cancer and leukemia group (CALGB). Proc. ASCO 17, 14a (1998).
66. Jackson-Grusby, L., Laird, P.W., Magge, S.N., Moeller, B.J. & Jaenisch, R. Mutagenicity of 5-aza-2̈-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc. Natl Acad. Sci. USA 94, 4681-4685 (1997).
67. Ramchandani, S., MacLeod, A.R., Pinard, M., von Hofe, E. & Szyf, M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxy-nucleotide. Proc. Natl Acad. Sci. USA 94, 684-689 (1997).
68. Sakai, T. et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48, 880-888 (1991).
69. Greenblatt, M.S., Bennett, W.P., Hollstein, M. & Harris, C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
70. Myohanen, S.K., Baylin, S.B. & Herman, J.G. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 58, 591-593 (1998).
71. Yeager, T.R. et al. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12, 163-174 (1998).
72. Flores, J.F. et al. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds. Oncogene 15, 2999-3005 (1997).
73. Batova, A. et al. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 57, 832-836 (1997).
74. Hiltunen, M.O. et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int. J. Cancer 70, 644-648 (1997).